ConductScience.org, home

Paper39997751

Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.

Rondanelli M and 13 others. Metabolites, 2025. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management. Papers, record 39997751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39997751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.
PubMed
Journal
Metabolites
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
6.76, provisional
iCite
Revised in PubMed
2025-02-27
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rondanelli MMariangelahttps://orcid.org/0000-0001-8336-4851
2Borromeo SSara
3Cavioni AAlessandro
4Gasparri CClarahttps://orcid.org/0000-0002-1088-6648
5Gattone IIlaria
6Genovese EElisa
7Lazzarotti AAlessandro
8Minonne LLeonardohttps://orcid.org/0009-0004-1421-199X
9Moroni AAlessiahttps://orcid.org/0000-0003-3780-2931
10Patelli ZZaira
11Razza CClaudia
12Sivieri CClaudia
13Valentini EMEugenio Marzio
14Barrile GCGaetan Claudehttps://orcid.org/0000-0001-8515-6132

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References289

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125314581Understanding the role of gut microbiome in metabolic disease risk.Pediatr Res2015https://conductscience.org/library/papers/25314581PubMed
228467925Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.Cell Metab2017https://conductscience.org/library/papers/28467925PubMed
333842424Probiotics, Pre-biotics and Synbiotics in the Treatment of Pre-diabetes: A Systematic Review of Randomized Controlled Trials.Front Public Health2021https://conductscience.org/library/papers/33842424PubMed
422297845Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.Nature2012https://conductscience.org/library/papers/22297845PubMed
530224347Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.Diabetes Care2018https://conductscience.org/library/papers/30224347PubMed
627711128Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.PLoS One2016https://conductscience.org/library/papers/27711128PubMed
724009397Gut microbiota from twins discordant for obesity modulate metabolism in mice.Science2013https://conductscience.org/library/papers/24009397PubMed
836615885Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota.Nutrients2023https://conductscience.org/library/papers/36615885PubMed
921411304Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.J Nutr Biochem2012https://conductscience.org/library/papers/21411304PubMed
1027713957Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota.Food Funct2016https://conductscience.org/library/papers/27713957PubMed
1135750555A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure.J Cardiol2022https://conductscience.org/library/papers/35750555PubMed
1227864387Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.Clin Chem2017https://conductscience.org/library/papers/27864387PubMed
1324299712Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women.Br J Nutr2014https://conductscience.org/library/papers/24299712PubMed
1426084343Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept.Diabetes Care2015https://conductscience.org/library/papers/26084343PubMed
1534361902Lactobacillus plantarum TWK10 Improves Muscle Mass and Functional Performance in Frail Older Adults: A Randomized, Double-Blind Clinical Trial.Microorganisms2021https://conductscience.org/library/papers/34361902PubMed
1631940332Plasma Trimethylamine-N-oxide and impaired glucose regulation: Results from The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS).PLoS One2020https://conductscience.org/library/papers/31940332PubMed
1738788020Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial.Medicine (Baltimore)2024https://conductscience.org/library/papers/38788020PubMed
1836176475Gut microbiota is a potential goalkeeper of dyslipidemia.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36176475PubMed
1921893047Effects of bacterial products on enterocyte-macrophage interactions in vitro.Biochem Biophys Res Commun2011https://conductscience.org/library/papers/21893047PubMed
2035760036Long-Term Dietary Effects on Human Gut Microbiota Composition Employing Shotgun Metagenomics Data Analysis.Mol Nutr Food Res2023https://conductscience.org/library/papers/35760036PubMed

See all 289 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42756900Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.Front Microbiol2026https://conductscience.org/library/papers/42756900PubMed
42750461Probiotics in Cardiometabolic Diseases: Current Evidence, Postbiotic Perspectives, and Future Directions.J Microbiol Biotechnol2026https://conductscience.org/library/papers/42750461PubMed
42745765Gut microbiota variation in admixed Hispanic populations with polyendocrine metabolic ovarian syndrome.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42745765PubMed
42346391Multi-Targeted Intervention of Eucommia ulmoides and Its Bioactive Constituents Against Metabolic Syndrome: From Molecular Mechanisms and Gut Microbiota Modulation to Clinical Translation.Metabolites2026https://conductscience.org/library/papers/42346391PubMed
42197276
Combined Probiotic Lactiplantibacillus plantarum ECGC 13110402 and Plant Sterol Supplement May Improve Lipids and Gut Microbiota in Coeliac Adults: A Randomised, Placebo-Controlled Pilot Human Intervention Study.
Molecules2026https://conductscience.org/library/papers/42197276PubMed
42051710Sarcopenia independently predicts acute cholecystitis in older patients with gallstones: a retrospective cohort study.Front Med (Lausanne)2026https://conductscience.org/library/papers/42051710PubMed
41994290Gut and skin microbial dysbiosis correlate with systemic inflammation and pruritus in immunological non-responders.Front Microbiol2026https://conductscience.org/library/papers/41994290PubMed
41971102Effects of Guanxinning tablet on the gut microbiota and bile acid metabolism in mice with hyperlipidemia.Front Pharmacol2026https://conductscience.org/library/papers/41971102PubMed
41830551Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host.Gut Microbes2026https://conductscience.org/library/papers/41830551PubMed
41828432Potential Links Between Aging, Mitochondrial Dysfunction, and Drug Transporter Function-Molecular Mechanisms and Pharmacokinetic Implications.Int J Mol Sci2026https://conductscience.org/library/papers/41828432PubMed
41756359Characteristic of different thermal treatment-induced dough protein oxidation and its impact on human gut microbiota.Curr Res Food Sci2026https://conductscience.org/library/papers/41756359PubMed
41754207Dietary Fiber in Endometriosis: Mechanisms, Evidence, and Potential Clinical Benefits-Up-to-Date Review.Nutrients2026https://conductscience.org/library/papers/41754207PubMed
41683289Dietary Nutrients, Gut Microbiota, and Cardiac Function: From Metabolic Mechanisms to Clinical Applications.Nutrients2026https://conductscience.org/library/papers/41683289PubMed
41596722Antioxidant and Anti-Inflammatory Activities of Probiotic Strains.Int J Mol Sci2026https://conductscience.org/library/papers/41596722PubMed
41596555Endometriosis as a Systemic and Complex Disease: Toward Phenotype-Based Classification and Personalized Therapy.Int J Mol Sci2026https://conductscience.org/library/papers/41596555PubMed
41374016Anthocyanins Modulation of Gut Microbiota to Reverse Obesity-Driven Inflammation and Insulin Resistance.Nutrients2025https://conductscience.org/library/papers/41374016PubMed
41010468Targeting the Gut Microbiota in Pediatric Obesity: A Paradigm Shift in Prevention and Treatment? A Comprehensive Review.Nutrients2025https://conductscience.org/library/papers/41010468PubMed
40901604Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression.World J Hepatol2025https://conductscience.org/library/papers/40901604PubMed
40869964The Gut-Endometriosis Axis: Genetic Mechanisms and Public Health Implications.Genes (Basel)2025https://conductscience.org/library/papers/40869964PubMed
40308638Quercetin ameliorates obesity and inflammation via microbial metabolite indole-3-propionic acid in high fat diet-induced obese mice.Front Nutr2025https://conductscience.org/library/papers/40308638PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39997751

GET https://conductscience.org/api/papers/v1/39997751/references?page=2